4baseCare, a precision oncology startup, has raised INR 90 crore ($9.8 million) in the first close of its Series B funding round. The round was led by well-known investors Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital.
The company will use the funding to expand its hospital-based genomics labs across India and to enter the Middle East, Southeast Asia, Latin America, and Central Asia.
It will also invest in improving its AI-powered precision oncology platform, OncoTwin, to help doctors make better treatment decisions for cancer.
Ashish Kacholia and Lashit Sanghvi, Co-leads for the round, said, “4baseCare is building a powerful genomics and AI-driven clinical intelligence platform for inclusive precision oncology. With strong hospital partnerships enabling access to world-class diagnostics for patients in clinical settings, the company is well-positioned to scale across emerging markets and expand its delivery model for maximum patient benefit.”
Hitesh Goswami, CEO of 4baseCare, said, “This funding will help us scale globally while building OncoTwin as an AI-driven decision support platform that learns from real-world clinico-genomic outcomes and supports oncologists with faster, more confident insights.”
4baseCare is a Bengaluru-based startup founded by Hitesh Goswami. It focuses on improving cancer diagnosis and treatment for underrepresented populations by building population-specific clinical and genomic data.
The company combines genetic testing with real-world patient data to provide doctors with clear, actionable insights that help them make better treatment decisions.
4baseCare’s OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center in New York, highlighting its growing global recognition.
Read More- Property Finder raises $170 million in funding from Mubadala
